Volume 25, Number 1—January 2019
Synopsis
Clinical and Radiologic Characteristics of Human Metapneumovirus Infections in Adults, South Korea
Table 4
Characteristic | Recovered, n = 802 | 30-day mortality rate, n = 47 | Univariate analysis |
Multivariable analysis |
|||
---|---|---|---|---|---|---|---|
OR (95% CI) | p value | OR (95% CI) | p value | ||||
Age |
63.5 (53.0–73.0) |
67.0 (55.0–77.0) |
(0.99–1.04) |
0.15 |
1.02 (1.00–1.05) |
0.11 |
|
Male sex |
416 (52) |
26 (55) |
0.87 (0.48–1.57) |
0.65 |
|||
Smoking | 0.04 | 0.54 | |||||
Never | 540 (67) | 25 (53) | 1 | 1 | |||
Former | 48 (6) | 3 (6) | 1.35 (0.39–4.63) | 0.63 | 0.67 (0.15–3.04) | 0.61 | |
Current |
214 (27) |
19 (40) |
1.92 (1.04–3.56) |
0.04 |
1.35 (0.69–2.64) |
0.39 |
|
Body mass index, kg/m2 |
23.1 (20.5–25.6) |
20.5 (18.2–24.1) |
0.89 (0.79–0.95) |
0.001 |
0.86 (0.79–0.95) |
0.002 |
|
Diabetes mellitus | 277 (35) | 19 (40) | 1.29 (0.71–2.35) | 0.41 | 1.48 (0.77–0.95) | 0.24 | |
Community-acquired pneumonia | 715 (89) | 40 (85) | 0.70 (0.30–1.60) | 0.39 | 0.83 (0.32–2.11) | 0.69 | |
Other pathogen |
193 (24) |
10 (21) |
0.86 (0.42–1.76) |
0.68 |
0.75 (0.35–1.60) |
0.45 |
|
Underlying condition | 0.02 | 0.02 | |||||
Immunocompetent | 443 (55) | 16 (34) | 1 | ||||
Solid tumor | 157 (20) | 17 (36) | 3.00 (1.48–6.08) | 0.002 | 3.43 (1.58–7.44) | 0.002 | |
SOT | 59 (7) | 0 | 0.00 (0.00–0.00) | 1.00 | 0.00 (0.00–0.00) | 1.00 | |
HCT | 7 (0.9) | 2 (4) | 7.91 (1.52–41.1) | 0.01 | 9.19 (1.47–57.37) | 0.02 | |
HM | 53 (7) | 5 (11) | 2.61 (0.92–7.42) | 0.07 | 3.44 (1.14–10.34) | 0.03 | |
Steroid use | 83 (10) | 7 (15) | 2.34 (0.93–5.85) | 0.07 | 2.40 (0.91–6.34) | 0.08 |
*Values are no. (%) or median (interquartile range). HCT, hematologic stem cell transplantation; HM, hematologic malignancy; OR, odds ratio; SOT, solid organ transplants.
Page created: December 18, 2018
Page updated: December 18, 2018
Page reviewed: December 18, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.